about
Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21.Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomasFine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions.Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia.SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia.Early ultrasonographic finding of septic thrombophlebitis is the main indicator of central venous catheter removal to reduce infection-related mortality in neutropenic patients with bloodstream infection.Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy.Impairment of circulating endothelial progenitors in Down syndrome.Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study.Toxoplasma gondii infection in patients with hematological malignancies.Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative HBcAb-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies.Clonal B-cell population in a reactive lymph node in acquired immunodeficiency syndrome.Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis.Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung.B-cell non-Hodgkin lymphoma and pseudo-Gaucher cells in a lymph node fine needle aspiration.Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity.Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registryEvaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B RegistryThyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin’s LymphomaDosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphomaExcellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin’s lymphomaBrentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphomaTenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCLFine-needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleenMeasurement of spleen volume by ultrasound scanning in patients with thrombocytosis: a prospective studyAspergillus niger infection in patients with haematological diseases: a report of eight casesImproved management of neutropenic enterocolitis using early ultrasound scan and vigorous medical treatmentRandomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphomaImatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
P50
Q33356859-45DD998A-881B-4E6A-88F4-D8F06DEF4C92Q33886396-22DB0832-8857-42AC-A543-80D2C4129CFEQ34435278-95C1E824-63DB-4464-B3B4-D7EA7A1E5FAEQ35083893-88A43D29-6B9D-47A9-909D-54DC5B80DFFCQ35669340-829A869D-3AF0-4FE2-9E15-100EB84D6BB9Q36715906-0A83A06D-5786-4428-92CD-2E96E7DD48C2Q38202697-0C6B8AB0-A1B7-4120-A284-BAA8F4D6C1D3Q38221844-9510C1A4-9B76-469A-A34A-95638674DEFCQ39054053-8F165853-EB6F-4699-B25C-F97D04D794DEQ39494051-D82C6CF4-B83A-4B84-8174-15AE3764C2B4Q40299877-4E1C3975-AEA7-4F3E-9407-8F3522E44E83Q40583859-0561E9BF-7243-4255-971A-2B6026B20C54Q41519138-4AB75AE6-9C3E-4EA3-A139-43F7010BBFBDQ42067838-F3319BC7-49FD-431B-BC29-D9A0DCCFA024Q43718029-6D5E7B82-98A2-4196-9C6A-C87B0AAE1419Q45017834-45518F05-F132-4DF0-832B-256A332023B5Q45296433-A8C62FE8-EDD0-42DF-BA57-415A5D67814CQ45414216-78DC52B4-707C-4EFF-8E79-381A23F81D8DQ45937373-509D97BC-4529-4E52-85D0-6C49F1726059Q46042938-E932528D-0F36-482B-A514-1F388249541AQ46647459-C5FE9985-0D51-4EB8-B71C-ED67020C54D0Q46662101-56392F5B-BA32-4786-A437-D3F7A65B91F7Q50462318-E8D28A18-C9BD-43A5-A784-D0417807763BQ50802868-892B432E-ADCF-4A03-8000-440CBB2DC9CDQ53383461-3CB1FA79-F234-4F20-B785-FF4400220A56Q53483898-E714DE12-C80C-445D-9882-4DEC3A868DB8Q54212283-EB00513F-A497-4C6B-8F0A-32F4030C963BQ56969009-3DD1D479-3CB8-416E-9830-08E2E2D9F722Q60171344-42EDE39F-80DA-4523-ACF9-A22B10ACB1C1Q60177869-114A4F84-F5F8-4049-877F-79D1C2965A21Q60177871-87962B4A-1BBF-4FEF-95BE-F5BDD6D1AF45Q61929002-18EAA0BA-B23C-41AB-873F-C1CB322E7B0BQ64055232-D319F043-60BB-454A-A43A-E8FE839F0378Q64241456-D47D90C6-BA1A-46E7-A7AB-082FD0EA2B3BQ73294087-2C5E3F7A-4476-4F48-89EA-661B27D320A1Q74098023-D13CF320-0F9E-45CE-AC21-1CC21759A7B4Q79913386-16E47C26-9C2C-4C96-8524-B62B688233B0Q80543945-3FF81365-08E9-4DAF-88CB-3244B7311FF9Q80558282-E23C38E0-1DF8-420B-9016-15ADB79C4B88Q80783866-B1DB7255-2C25-47A8-A169-7718E04C966F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marco Picardi
@ast
Marco Picardi
@en
Marco Picardi
@es
Marco Picardi
@nl
type
label
Marco Picardi
@ast
Marco Picardi
@en
Marco Picardi
@es
Marco Picardi
@nl
prefLabel
Marco Picardi
@ast
Marco Picardi
@en
Marco Picardi
@es
Marco Picardi
@nl
P106
P1153
56402972500
7003787190
P21
P31
P496
0000-0001-8508-2524